Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Board
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step

    M.A. Granatkin, Evgenii Aleksandrovich Nikitin, E.S. Mikhailov, V.A. Doronin, S.V. Minenko, M.M. Okuneva, N.V. Degtyareva, M.E. Pochtar, S.A. Lugovskaya, Yu.N. Kobzev, O.Yu. Vinogradova, V.V. Ptushkin
    282-288
    01.07.2022
  • Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

    E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey
    271-281
    01.07.2022
  • Efficacy and Safety of Pola-BR Combination in Relapsed/Refractory Aggressive В-Cell Non-Hodgkin’s Lymphomas: A Russian Multi-Center Study

    Olesya Gennadevna Smykova, A.A. Semenova, Yu.B. Chernykh, T.A. Mitina, A.V. Kildyushevskii, S.K. Kravchenko, A.E. Misyurina, A.U. Magomedova, E.A. Baryakh, S.V. Samarina, N.P. Volkov, V.V. Markelov, P.V. Kotselyabina, L.V. Fedorova, K.V. Lepik, E.V. Kondakova, L.V. Stelmakh, V.V. Baykov, N.B. Mikhailova, I.S. Moiseev, G.S. Tumyan, E.A. Osmanov, A.D. Kulagin
    232-239
    01.07.2022
  • Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects

    Anna Yurevna Aksenova, A.S. Zhuk, E.I. Stepchenkova, S.V. Gritsaev
    259-270
    01.07.2022
  • Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020

    T.I. Ionova, E.A. Andreevskaya, E.N. Babich, N.B. Bulieva, O.Yu. Vinogradova, E.M. Volodicheva, S.V. Voloshin, N.N. Glonina, S.K. Dubov, N.B. Esef’eva, A.Yu. Zaritskey, E.E. Zinina, M.O. Ivanova, T.Yu. Klitochenko, A.V. Kopylova, A.D. Kulagin, G.B. Kuchma, O.Yu. Li, E.G. Lomaia, A.L. Melikyan, V.Ya. Melnichenko, S.N. Menshakova, N.V. Minaeva, T.A. Mitina, E.V. Morozova, Tatyana Pavlovna Nikitina, O.E. Ochirova, A.S. Polyakov, T.I. Pospelova, A.V. Proidakov, O.A. Rukavitsyn, G.Sh. Safuanova, I.N. Subortseva, M.S. Fominykh, M.V. Frolova, T.V. Shelekhova, D.G. Sherstnev, T.V. Shneider, V.A. Shuvaev, Z.K. Abdulkhalikova, L.V. Anchukova, I.A. Apanaskevich, A.N. Arnautova, M.V. Barabanshchikova, N.V. Berlina, A.P. Bityukov, E.A. Gilyazitdinova, V.I. Gilmanshina, E.K. Egorova, E.V. Efremova, E.B. Zhalsanova, E.N. Kabanova, O.B. Kalashnikova, A.E. Kersilova, T.I. Kolosheinova, P.M. Kondratovskii, E.V. Koroleva, A.N. Kotelnikova, N.A. Lazareva, N.S. Lazorko, E.V. Lyyurova, A.S. Lyamkina, Yu.N. Maslova, E.S. Mileeva, N.E. Mochkin, E.K. Nekhai, Ya.A. Noskov, E.S. Osipova, M.M. Pankrashkina, E.V. Potanina, O.D. Rudenko, T.Yu. Rozhenkova, E.I. Sbityakova, N.T. Siordiya, A.V. Talko, E.I. Usacheva, Yu.B. Chernykh, T.V. Chitanava, K.S. Shashkina, D.I. Shikhbabaeva, K.S. Yurovskaya
    176-197
    01.04.2022
  • Efficacy and Safety of Midostaurin Combined with Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

    Sergei Nikolaevich Bondarenko, A.G. Smirnova, B.I. Ayubova, E.V. Karyagina, O.S. Uspenskaya, Yu.S. Neredko, A.P. Kochergina, I.A. Samorodova, E.A. Pashneva, Yu.S. Chernykh, Yu.A. Dunaev, N.B. Esef’eva, R.K. Il’yasov, T.I. Brazhkina, I.A. Novokreshchenova, Z.K. Simavonyan, E.I. Kuzub, V.I. Bakhtina, T.I. Olkhovich, M.V. Burundukova, E.V. Babenko, Yu.D. Oleinikova, I.M. Barkhatov, T.L. Gindina, I.S. Moiseev, A.D. Kulagin
    167-175
    01.04.2022
  • Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

    Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva
    119-129
    01.04.2022
  • Treatment of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

    Aleksander Sergeevich Luchinin
    130-139
    01.04.2022
  • Significance of the Expression of pAKT1 and pSyk Activation Proteins in Diffuse Large B-Cell Lymphoma

    Elena Viktorovna Vaneeva, V.A. Rosin, D.A. Dyakonov, S.V. Samarina, I.V. Paramonov
    140-147
    01.04.2022
  • Pharmacoeconomic Analysis of CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemias

    Irina Vladimirovna Gribkova, A.A. Zavyalov
    205-212
    01.04.2022
  • ROR-1 Expression in the Diagnosis and Monitoring of Minimal Residual Disease in Chronic Lymphocytic Leukemia

    Evgenii Vladimirovich Pochtar, S.A. Lugovskaya, E.V. Naumova, E.A. Dmitrieva, V.V. Dolgov
    148-155
    01.04.2022
  • The Efficacy of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin’s Lymphoma and Quality of Life: Results of a Multi-Center Observational Prospective Study in the Context of Real Clinical Practice

    T.I. Ionova, A.A. Amdiev, M.I. Andrievskikh, E.A. Baryakh, E.V. Vasilev, M.V. Volkov, E.M. Volodicheva, V.V. Ivanov, O.V. Kaverina, K.D. Kaplanov, T.Yu. Klitochenko, V.I. Kurakin, D.G. Lazareva, O.G. Larionova, K.V. Lepik, I.B. Lysenko, V.Ya. Melnichenko, R.I. Minullina, O.V. Mironov, E.N. Misyurina, N.B. Mikhailova, N.E. Mochkin, Tatyana Pavlovna Nikitina, T.S. Petrova, N.M. Porfireva, O.A. Rukavitsyn, A.A. Samoilova, R.N. Safin, P.I. Simashova, E.G. Smirnova, N.A. Trenina, N.V. Fadeeva, G.N. Khusainova, V.L. Chang, T.V. Shelekhova, D.G. Sherstnev
    42-53
    01.01.2022
  • Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

    Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin
    28-41
    01.01.2022
  • Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Mai

    A.G. Turkina, Margarita Anatolevna Gurianova, E.Yu. Chelysheva, O.A. Shukhov
    54-61
    01.01.2022
  • A Rationale for a New Operational Integrated Quality and Efficiency Index for Assessing the Performance of Hematological Services in Constituent Entities of the Russian Federation

    Elena Nikolaevna Parovichnikova, T.Ts. Garmaeva, O.V. Lazareva, K.A. Lukina, Yu.A. Chabaeva, S.M. Kulikov, V.V. Troitskaya, T.V. Gaponova, L.I. Menshikova, V.G. Savchenko
    1-15
    01.01.2022
  • Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

    A.A. Klodzinskii, I.A. Pivovarova, L.G. Turgunova, Aimzhan Zharkynovna Anafina, A.V. Zinchenko
    69-75
    01.01.2022
  • Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

    A.S. Kolbin, Yuliya Mikhailovna Gomon, Yu.E. Balykina, M.A. Proskurin
    85-96
    01.01.2022
  • Current Aspects in Early Diagnosis of Cardiotoxic Complications of Drug Therapy in Oncology: A Literature Review

    Geliya Rifkatovna Gimatdinova, O.E. Danilova, I.L. Davydkin, R.K. Khairetdinov, L.A. Rogozina
    107-113
    01.01.2022
  • Artificial Intelligence in Hematology

    Aleksandr Sergeevich Luchinin
    16-27
    01.01.2022
  • Results of the Russian Multi-Center Cooperative Prospective-Retrospective Observational Program for Hodgkin’s Lymphoma Treatment RNWOHG-HD1

    Ivan Sergeevich Moiseev, S.M. Alekseev, N.B. Mikhailova, K.D. Kaplanov, M.V. Demchenkova, L.V. Anchukova, V.V. Baikov, A.M. Belyaev, Yu.A. Vasil’eva, N.P. Volkov, Yu.N. Vinogradova, A.Yu. Zaritskey, A.E. Zdorov, N.V. Il’in, L.O. Kashintseva, E.V. Kondakova, P.V. Kotselyabina, V.A. Lapin, K.V. Lepik, I.V. Lesechko, V.M. Moiseenko, G.M. Manikhas, N.V. Medvedeva, Yu.A. Oleinik, E.S. Pavlyuchenko, K.S. Parfenova, E.V. Patrakova, A.V. Proidakov, D.V. Saidullaeva, E.V. Tarasova, A.L. Shipaeva, T.V. Shneider, B.V. Afanasyev
    455-465
    01.10.2021
  • Langerhans Cell Histiocytosis in Adults: Treatment Opportunities of Today

    Vitalii Dmitrievich Latyshev, E.A. Lukina
    444-454
    01.10.2021
  • Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

    Ekaterina Yurevna Chelysheva, M.A. Guryanova, A.G. Turkina
    427-435
    01.10.2021
  • Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review

    Aleksandra Vladimirovna Semyanikhina, E.E. Tolstykh
    436-443
    01.10.2021
  • Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

    Nadezhda Viktorovna Kurkina, E.A. Repina
    488-495
    01.10.2021
  • Carmustine in the Therapy of B-Cell Lymphomas

    Daria Aleksandrovna Koroleva, E.E. Zvonkov
    496-502
    01.10.2021
  • Multiple Myeloma and Dendritic Cell Vaccines

    Irina Vladimirovna Gribkova, A.A. Zavyalov
    370-377
    01.07.2021
  • Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

    Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva
    321-332
    01.07.2021
  • Treatment of Mastocytosis: A Literature Review

    Karina Maksimovna Chernavina, A.S. Orlova, E.A. Nikitin
    361-369
    01.07.2021
  • Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

    Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova
    299-307
    01.07.2021
  • Potential Predictors and Response Quality after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

    Ivan Ivanovich Kostroma, Zh.Yu. Sidorova, N.Yu. Semenova, A.A. Zhernyakova, R.R. Sabitova, S.P. Svitina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev
    333-339
    01.07.2021
  • Immune Reconstitution Inflammatory Syndrome and Hodgkin’s Lymphoma

    Aleksandr Vasilevich Pivnik, A.M. Vukovich, A.A. Petrenko
    378-385
    01.07.2021
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

    Anait Levonovna Melikyan, A.M. Kovrigina, I.N. Subortseva, V.A Shuvaev, E.V. Morozova, E.G. Lomaia, B.V. Afanasyev, T.A. Ageeva, V.V. Baikov, O.Yu. Vinogradova, S.V. Gritsaev, A.Yu. Zaritskey, T.I. Ionova, K.D. Kaplanov, I.S. Martynkevich, T.A. Mitina, E.S. Polushkina, T.I. Pospelova, M.A. Sokolova, A.B. Sudarikov, A.G. Turkina, Yu.V. Shatokhin, R.G. Shmakov, V.G. Savchenko
    262-298
    01.04.2021
  • Use of Blinatumomab in Acute Lymphoblastic Leukemia in Municipal Healthcare: A Case Report

    Vasilii Anatolevich Shuvaev, O.V. Ushakova, E.I. Mullo, T.V. Tolstykh, N.Z. Triputen
    198-203
    01.04.2021
  • Mastocytosis in Adults: A Retrospective Analysis of the Clinical Course and Treatment of 58 Patients

    Vsevolod Gennadevich Potapenko, V.V. Baikov, I.E. Belousova, E.A. Belyakova, M.V. Barabanshchikova, D.V. Zaslavsky, I.S. Zyuzgin, A.V. Klimovich, Yu.A. Krivolapov, T.G. Kulibaba, E.V. Lisukova, E.E. Leenman, L.A. Mazurok, A.M. Maksimova, E.V. Morozova, A.S. Nizamutdinova, K.A. Skoryukova, E.A. Ukrainchenko, N.V. Medvedeva
    158-166
    01.04.2021
  • Nivolumab in a Primary Refractory Hodgkin’s Lymphoma Patient with Absolute Lymphopenia Prior to Chemotherapy: Literature Review and a Case Report

    Tatyana Ivanovna Bogatyreva, A.O. Afanasov, N.A. Falaleeva, L.Yu. Grivtsova, A.Yu. Terekhova
    179-187
    01.04.2021
  • Ovary Lesions in Classical Hodgkin’s Lymphoma

    Svetlana Yurevna Smirnova, T.N. Moiseeva, L.S. Al-Radi, A.B. Fedorov, S.A. Makhinya, N.V. Volkov, G.A. Yatsyk, I.A. Shupletsova, A.M. Kovrigina
    188-192
    01.04.2021
  • CAR-Т Cells for the Treatment of Chronic Lymphocytic Leukemia: Literature Review

    Irina Vladimirovna Gribkova, A.A. Zav’yalov
    225-230
    01.04.2021
  • Cardio-oncology and Oncohematology: Examination Algorithms, Prophylactic and Treatment of Cardiotoxicity, Trends in Rehabilitation

    Elena Ivanovna Emelina, G.E. Gendlin, I.G. Nikitin
    239-261
    01.04.2021
  • Organ Lesions in Adults with Secondary Hemophagocytic Syndrome

    Vsevolod Gennadevich Potapenko, A.V. Klimovich, D.D. Avdoshina, V.V. Baikov, N.V. Vinogradova, O.V. Goloshchapov, E.V. Doguzhieva, E.E. Zinina, G.V. Kachenya, Yu.A. Krivolapov, E.V. Karyagina, T.G. Kulibaba, S.V. Lapin, E.E. Leenman, E.S. Pavlyuchenko, N.A. Potikhonova, M.Yu. Pervakova, N.B. Popova, A.V. Rysev, V.V. Ryabchikova, E.A. Surkova, I.P. Fedunyak, N.V. Medvedeva
    91-102
    01.01.2021
  • Hodgkin’s Lymphoma in HIV-Infected Patients

    Aleksandr Vasilevich Pivnik, A.M. Vukovich, N.V. Kremneva, M.G. Dubnitskaya, A.V. Tsakhilova
    63-68
    01.01.2021
121 - 160 of 392 items << < 1 2 3 4 5 6 7 8 9 10 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
  • Issue 2 (2026)
  • Issue 3 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    2636
  • Primary Immune Thrombocytopenia in Children: An Analysis of the Therapy Efficacy in Compliance with the National Clinical Guidelines
    2629
  • Characteristic Features of the Novel Coronavirus Infection COVID-19 in Oncohematological Patients
    1476
  • The 5-Year Experience of the Reference Center for Differential Diagnosis of Hematolymphoid Tumors Based at the National Research Center for Hematology
    1400
  • Pola-R-CHP Regimen as First-Line Therapy for Diffuse Large B-Cell Lymphoma: A Retrospective Study of Real-World Clinical Practice
    1322

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up